NCT00540891View on ClinicalTrials.gov

The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score

PHASE3CompletedINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

October 31, 2004

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

ALFUZOSIN

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY